Lantus VA Coverage Pathway: How Veterans Get Insulin Glargine Through the VA

How the VA Formulary Handles Insulin Glargine

The VA National Formulary is managed by the Pharmacy Benefits Management (PBM) Services office within the Veterans Health Administration. Insulin glargine has been part of the VA's long-acting insulin options for years, though individual VA medical centers (VAMCs) can adjust local formulary preferences based on contract pricing and clinical pharmacy review.

Formulary vs. Non-Formulary Designation

A formulary listing means a VA provider can prescribe the drug without additional authorization. If a specific brand or formulation sits in non-formulary status at a particular VAMC, the prescriber submits a non-formulary request through the local Pharmacy and Therapeutics (P&T) committee. Approval rates for non-formulary insulin requests tend to be high when clinical need is documented, because the VA's mandate is to provide medically necessary care to enrolled veterans [1].

Biosimilar Preference at Many Facilities

The FDA approved Semglee (insulin glargine-yfgn) as the first interchangeable biosimilar insulin in 2021 [2]. Rezvoglar (insulin glargine-aglr) followed the same year. VA facilities frequently prefer biosimilars when they offer lower acquisition costs. A veteran prescribed "Lantus" may receive Semglee at the VA pharmacy window. This is clinically equivalent. The INSTRIDE trials demonstrated that biosimilar insulin glargine produced comparable HbA1c reductions and similar hypoglycemia rates to reference Lantus over 52 weeks [3].

How Contract Pricing Affects What You Receive

The VA negotiates drug prices under the Federal Supply Schedule (FSS), and these negotiated prices are often 40% to 50% below wholesale acquisition cost [4]. That buying power is why VA copays stay well below retail pharmacy prices. The specific insulin glargine product stocked at your VAMC depends on whichever manufacturer or biosimilar producer won the current contract cycle.

VA Copay Tiers for Insulin Glargine

Most veterans do not pay full price for prescriptions filled at VA pharmacies. The copay depends on your VA priority group and whether the medication is classified as Tier 1 (preferred generic/formulary), Tier 2, or Tier 3.

Priority Groups 1 Through 6

Veterans in priority groups 1 through 6, which include those with service-connected disabilities rated at 10% or higher, former POWs, Purple Heart recipients, and veterans with catastrophic disabilities, pay $0 for medications related to their service-connected conditions. For non-service-connected prescriptions, the standard outpatient copay is $5 for a 30-day supply of a Tier 1 medication and $11 for Tier 2 or Tier 3 [5].

Priority Groups 7 and 8

Veterans in groups 7 and 8 (higher income, no service-connected disability) pay the same $5 to $11 copay structure but do not qualify for the service-connected $0 copay exemption. Even at the $11 tier, this remains far below the average retail price of brand-name Lantus, which listed above $270 per vial before Sanofi's 2024 list-price reductions [6].

The Annual Copay Cap

The VA applies an annual outpatient medication copay cap. Once a veteran's total pharmacy copays for the calendar year reach the cap amount (which the VA updates periodically), all subsequent fills for the rest of that year cost $0. For 2025, the cap was $700 for priority group 7 and 8 veterans [5]. This ceiling provides a safety net for veterans taking multiple chronic medications, including insulin.

Step-by-Step: Getting Insulin Glargine Through the VA

The process is straightforward, but knowing each step prevents delays.

Step 1: Confirm VA Health Care Enrollment

You must be enrolled in VA health care. Veterans can apply online at VA.gov, by phone at 1-877-222-8387, or in person at any VAMC. Enrollment does not require a service-connected disability. Income-based eligibility thresholds apply to priority groups 7 and 8 [7].

Step 2: Schedule an Appointment With Your VA Provider

Request an appointment with your VA primary care physician or endocrinologist. If you already have a diabetes diagnosis and a prescription history for insulin glargine from a non-VA provider, bring your medication list and most recent HbA1c result. Your VA provider can enter the prescription into the VA's electronic health record system (VistA/CPRS or the newer Oracle Health platform at migrated sites).

Step 3: Fill at the VA Pharmacy or by Mail

You have two options. Pick up at your local VAMC outpatient pharmacy, often on the same day. Or request mail-order through the Consolidated Mail Outpatient Pharmacy (CMOP) system, which ships a 90-day supply directly to your home. CMOP fills carry the same copay-per-30-day calculation, so a 90-day fill equals three copays [5].

Step 4: Handle Non-Formulary Situations

If your VAMC's local formulary lists a different long-acting insulin (such as insulin degludec) as preferred, your provider may need to document why insulin glargine is specifically required. Common clinical justifications include prior therapeutic success with glargine, adverse reactions to the preferred agent, or patient preference based on device familiarity. The P&T committee review typically takes 3 to 7 business days.

How VA Coverage Compares to the Inflation Reduction Act $35 Cap

The Inflation Reduction Act (IRA), signed in August 2022, capped out-of-pocket insulin costs at $35 per month for Medicare Part D beneficiaries starting January 2023 [8]. This was a significant policy shift for Medicare enrollees. But for veterans using VA pharmacy benefits, the impact was minimal, because VA copays were already lower.

VA Copays Were Already Below $35

A veteran in priority group 1 through 6 filling insulin glargine for a service-connected condition pays $0. A veteran in groups 7 or 8 pays $5 to $11 per 30-day supply. Both figures sit well under the IRA's $35 threshold. The VA system's Federal Supply Schedule pricing and congressionally mandated copay structure had effectively solved the insulin affordability problem for enrolled veterans years before the IRA passed.

Dual-Eligible Veterans

Some veterans qualify for both VA health care and Medicare Part D. If you fill insulin at a retail pharmacy using Medicare Part D, the $35 cap applies there. If you fill at the VA pharmacy, VA copay rules apply instead. Dual-eligible veterans should compare costs each fill cycle. In nearly every scenario, the VA pharmacy remains cheaper, and CMOP mail-order adds the convenience of home delivery.

Sanofi Patient Assistance and Savings Programs

Veterans who do not use VA pharmacy benefits, or who are in the process of enrolling, may need interim coverage. Sanofi operates several programs that reduce out-of-pocket costs for insulin glargine.

Insulins Valyou Savings Program

This program caps the cost of Lantus at $35 per month for patients without insurance or those who choose not to use insurance. No income verification is required. The program covers up to 10 boxes of Lantus SoloSTAR pens or 10 vials per fill [6]. It is not valid for patients using government insurance (Medicare, Medicaid, Tricare, or VA benefits), so it functions as a bridge for veterans awaiting VA enrollment rather than a complement to VA coverage.

Sanofi Patient Connection

For uninsured patients whose household income falls below 400% of the federal poverty level, Sanofi's Patient Connection program provides Lantus at no cost [6]. Application requires proof of income and a valid prescription. Veterans discharged from service but not yet enrolled in VA health care may qualify during the enrollment gap.

Retail Pharmacy Discount Cards

GoodRx and similar platforms show cash prices for insulin glargine (biosimilar) at approximately $35 to $70 per vial at major retail chains, reflecting the market impact of biosimilar competition and Sanofi's list-price reductions [9]. These prices apply at non-VA pharmacies and can serve as a fallback for veterans who need a fill before their VA prescription is set up.

Clinical Context: Why Insulin Glargine Remains a First-Line Basal Insulin

Insulin glargine has been a standard basal insulin since its FDA approval in 2000 [10]. Understanding its clinical standing helps veterans discuss treatment options with their VA providers.

Efficacy Data

The ORIGIN trial (Outcome Reduction with an Initial Glargine Intervention, N=12,537) demonstrated that early use of insulin glargine in people with dysglycemia reduced progression to type 2 diabetes and maintained HbA1c at median 6.2% over 6.2 years of follow-up, with a neutral effect on cardiovascular outcomes [11]. The American Diabetes Association (ADA) 2025 Standards of Care list insulin glargine as a recommended basal insulin option for type 2 diabetes when oral agents alone do not achieve glycemic targets [12].

Safety Profile

Hypoglycemia is the primary risk. In ORIGIN, the rate of severe hypoglycemia was 1.00 event per 100 person-years in the glargine group versus 0.31 in the standard-care group [11]. Weight gain averaged 1.6 kg more than standard care over the study period. These numbers matter for shared decision-making at VA appointments.

Head-to-Head With Insulin Degludec

The SWITCH 2 trial (N=721) compared insulin degludec to insulin glargine U100 in type 2 diabetes patients at high hypoglycemia risk. Degludec showed a 30% lower rate of overall symptomatic hypoglycemia (rate ratio 0.70, 95% CI 0.61 to 0.80) [13]. Some VA formularies prefer degludec based on these data. If your VAMC stocks degludec as the preferred long-acting insulin, your provider can still request glargine through non-formulary channels if clinically appropriate.

Community Care and Non-VA Pharmacy Fills

Veterans eligible for VA community care (under the MISSION Act) may receive prescriptions from non-VA providers. In these cases, the prescription can still be filled at a VA pharmacy or CMOP to maintain VA copay rates. If you fill at a community retail pharmacy through an authorized community care referral, copay rules differ and may be higher [14].

How to Route a Community Care Prescription to the VA Pharmacy

Ask the community care provider to send the prescription electronically to your assigned VAMC pharmacy. Most VAMCs accept e-prescriptions through Surescripts. Alternatively, bring a paper prescription to your VAMC pharmacy window. The pharmacist will verify your VA eligibility and enrollment, then fill and dispense under standard VA copay rules.

When Retail Fill Is the Only Option

If a veteran needs insulin urgently and cannot reach a VA pharmacy, they can fill at a retail pharmacy and submit a reimbursement request to VA. The VA will reimburse at its negotiated rate if the fill was for an authorized prescription and the veteran was unable to use a VA pharmacy due to distance or emergency circumstances [14]. Keep all receipts and pharmacy documentation.

Special Considerations for Insulin Glargine at the VA

Pen Devices vs. Vials

VA pharmacies stock both Lantus SoloSTAR pens and vials (or their biosimilar equivalents). Pens are often preferred for veterans with dexterity limitations or visual impairment. The VA copay applies per dispensing unit regardless of formulation. If you prefer pens, tell your VA provider so the prescription specifies the pen device.

Refrigeration and CMOP Shipping

Insulin glargine requires refrigeration until first use, then can be stored at room temperature for up to 28 days [10]. CMOP shipments include cold-chain packaging with gel packs. During summer months, the VA uses insulated mailers rated for temperature excursions. If your insulin arrives warm or the cold pack is fully melted, contact CMOP at 1-888-385-0235 for a replacement shipment at no additional cost.

Transition From Active Duty to VA Care

Service members transitioning from TRICARE to VA health care should request a 90-day bridge supply of insulin glargine from their military treatment facility pharmacy before separation. This prevents gaps while VA enrollment processes, which can take 2 to 4 weeks for health care and an additional 1 to 2 weeks for pharmacy access at the assigned VAMC.

Dr. Robert Vigersky, former Chief of Endocrinology at Walter Reed National Military Medical Center, has noted: "The transition from military to VA health care is a high-risk period for insulin-dependent veterans. A 90-day bridge supply and proactive enrollment are the best safeguards against treatment interruption" [15].

The ADA's 2025 Standards of Care reinforce this point: "Continuity of insulin therapy during care transitions is essential to prevent hyperglycemic emergencies, particularly in patients on basal-bolus regimens" [12].